Pemvidutide (ALT-801) DDI Study in Healthy Volunteers

Clinical trial NCT04972396 · COMPLETED

Trial details

NCT number: NCT04972396
Sponsor: Altimmune, Inc.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

NASH - Nonalcoholic Steatohepatitis

Start date: 2021-09-15
Primary completion: 2022-05-15
Enrollment: 40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.